Astellas Pharma
4503.T
$9.46
Share price
-1.51%
Change (1 day)
-37.02%
Change (1 year)
Categories
Revenue for Astellas Pharma (4503.T)
Revenue in 2023 (TTM): $10.86 B
According to Astellas Pharma's latest financial reports the company's current revenue (TTM) is $10.86 B. In 2022 the company made a revenue of $10.99 B a decrease over the years 2021 revenue that were of $11.61 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Astellas Pharma from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $10.86 B | -1.16% |
| 2022 | $10.99 B | -5.37% |
| 2021 | $11.61 B | -1.71% |
| 2020 | $11.81 B | -0.12% |
| 2019 | $11.83 B | -0.07% |
| 2018 | $11.84 B | 1.85% |
| 2017 | $11.62 B | -4.31% |
| 2016 | $12.15 B | 7.88% |
| 2015 | $11.26 B | 1.48% |
| 2014 | $11.09 B | -2% |
| 2013 | $11.32 B | -3.7% |
| 2012 | $11.76 B | -5.31% |
| 2011 | $12.42 B | 14.28% |
| 2010 | $10.86 B | 4.53% |
| 2009 | $10.39 B |